nach oben

Erschienen in:

01.02.2010

Glutathione and Malondialdehyde Levels in Late Pulmonary Complications of Sulfur Mustard Intoxication

verfasst von: Majid Shohrati, Mostafa Ghanei, Navvab Shamspour, Fatemeh Babaei, Majid Norozi Abadi, Mahvash Jafari, Amini Harandi Ali

Erschienen in: Lung | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

It has been hypothesized that antioxidant and oxidant capacities may be related to the severity of obstructive lung impairment in patients with sulfur mustard (SM)-induced lung injuries. Our study was designed to measure the level of glutathione (GSH) and malondialdehyde (MDA) activities in patients intoxicated with SM and to evaluate the relationship between their activity and the severity of pulmonary dysfunction. A total of 250 patients with a history of exposure to a single high dose of SM gas and also 60 healthy nonsmoking individuals with no history of exposure to SM were selected. All patients underwent spirometry; based on its indices they were divided into two groups: mild (n = 140) and moderate-to-severe (n = 110) pulmonary dysfunction. Also, serum GSH and MDA concentration measurements were performed for all patients and controls. The mean GSH level in controls was 29.85 ± 3.26 μmol/ml, which was significantly higher than in patients with mild and moderate-to-severe pulmonary dysfunction (19.02 ± 2.36 and 17.89 ± 2.16 μmol/ml, respectively). Also, the mean MDA level in controls was 0.69 ± 0.09 μmol/ml, which was significantly lower than in patients with mild and moderate-to-severe pulmonary dysfunction (0.74 ± 0.05 and 0.75 ± 0.05 μmol/ml, respectively). There was a weak linear correlation between GSH level and some of the pulmonary function indices. On the other hand, there was no significant relationship between the MDA level and pulmonary indices. Our study confirmed important alterations in the oxidative-antioxidative system in patients suffering from SM-induced lung injuries, as shown by a decreased serum level of GSH and an increased level of MDA. Individuals with moderate-to-severe SM-induced lung injuries show a greater tendency for a decreased level of GSH and an increased level of MDA than those with mild injuries; however, there is only minimal association between pulmonary function parameters and the serum level of MDA and GSH. These findings encourage us to examine therapeutic measures to correct such imbalances in future studies.

Elsayed NM, Omaye ST (2004) Biochemical changes in mouse lung after subcutaneous injection of the sulfur mustard 2-chloroethyl 4-chlorobutyl sulfide. Toxicology 199:195–206CrossRefPubMed

Emad A, Rezaian GR (1999) Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest 115:1346–1351CrossRefPubMed

Ghanei M, Shohrati M, Jafari M, Ghaderi S, Alaeddini F, Aslani J (2008) N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test. Basic Clin Pharmacol Toxicol 103:428–432CrossRefPubMed

Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D (2003) Incidence of lung, eye and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45:1136–1143CrossRefPubMed

Tsukagoshi H, Shimizu Y, Iwamae S, Hisada T, Ishizuka T, Iizuka K, Dobashi K, Mori M (2000) Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline. Respir Med 94:584–588CrossRefPubMed

Health America of Pennsylvania, Inc. (2008) Clinical Practice Guidelines Management of COPD. Available at http://healthamerica.coventryhealthcare.com/web/groups/public/@cvty_regional_chcpa/documents/webcontent/c042490.pdf

Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502–522CrossRefPubMed

Satoh K (1978) Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 90:37–43CrossRefPubMed

Pant SC, Vijayaraghavan R, Kannan GM, Ganesan K (2000) Sulfur mustard induced oxidative stress and its prevention by sodium 2,3-dimercapto propane sulphonic acid (DMPS) in mice. Biomed Environ Sci 13:225–232PubMed

10.

Vijayaraghavan R, Gautam A, Kumar O, Pant SC, Sharma M, Singh S, Kumar HT, Singh AK, Nivsarkar M, Kaushik MP, Sawhney RC, Chaurasia OP, Prasad GB (2006) Protective effect of ethanolic and water extracts of sea buckthorn (Hippophae rhamnoides L.) against the toxic effects of mustard gas. Indian J Exp Biol 44:821–831PubMed

11.

Vijayaraghavan R, Sugendran K, Pant SC, Husain K, Malhotra RC (1991) Dermal intoxication of mice with bis(2-chloroethyl)sulphide and the protective effect of flavonoids. Toxicology 69(1):35–42CrossRefPubMed

12.

Kumar O, Sugendran K, Vijayaraghavan R (2001) Protective effect of various antioxidants on the toxicity of sulfur mustard administered to mice by inhalation or percutaneous routes. Chem Biol Interact 134:1–12CrossRefPubMed

13.

McClintock SD, Hoesel LM, Das SK, Till GO, Neff T, Kunkel RG, Smith MG, Ward PA (2006) Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J Appl Toxicol 26:126–131CrossRefPubMed

14.

Han S, Espinoza LA, Liao H, Boulares AH, Smulson ME (2004) Protection by antioxidants against toxicity and apoptosis induced by the sulfur mustard analog 2-chloroethylethyl sulphide (CEES) in Jurkat T cells and normal human lymphocytes. Br J Pharmacol 141:795–802CrossRefPubMed

15.

Naghii MR (2002) Sulfur mustard intoxication, oxidative stress, and antioxidants. Mil Med 167:573–575PubMed

16.

Smith KJ, Hurst CG, Moeller RB, Skelton HG, Sidell FR (1995) Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. J Am Acad Dermatol 32:765–776CrossRefPubMed

17.

Russell D, Blain PG, Rice P (2006) Clinical management of casualties exposed to lung damaging agents: a critical review. Emerg Med J 23:421–424CrossRefPubMed

18.

Dekhuijzen PN (2006) Acetylcysteine in the treatment of severe COPD. Ned Tijdschr Geneeskd 150:1222–1226PubMed

19.

Griffith OW, Mulcahy RT (1999) The enzymes of glutathione synthesis: gamma-glutamylcysteine synthetase. Adv Enzymol Relat Areas Mol Biol 73:209–267CrossRefPubMed

20.

Vahrmeijer AL, van Dierendonck JH, Schutrups J, van de Velde CJ, Mulder GJ (1999) Effect of glutathione depletion on inhibition of cell cycle progression and induction of apoptosis by melphalan (l-phenylalanine mustard) in human colorectal cancer cells. Biochem Pharmacol 58:655–664CrossRefPubMed

21.

Colvin OM, Friedman HS, Gamcsik MP, Fenselau C, Hilton J (1993) Role of glutathione in cellular resistance to alkylating agents. Adv Enzyme Regul 33:19–26CrossRefPubMed

22.

Amir A, Chapman S, Gozes Y, Sahar R, Allon N (1998) Protection by extracellular glutathione against sulfur mustard induced toxicity in vitro. Hum Exp Toxicol 17:652–660CrossRefPubMed

23.

Gross CL, Innace JK, Hovatter RC, Meier HL, Smith WJ (1993) Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard. Cell Biol Toxicol 9:259–267CrossRefPubMed

24.

Smith CN, Lindsay CD, Upshall DG (1997) Presence of methenamine/glutathione mixtures reduces the cytotoxic effect of sulfur mustard on cultured SVK-14 human keratinocytes in vitro. Hum Exp Toxicol 16:247–253CrossRefPubMed

25.

Atkins KB, Lodhi IJ, Hurley LL, Hinshaw DB (2000) N-acetylcysteine and endothelial cell injury by sulfur mustard. J Appl Toxicol 20(suppl 1):S125–S128CrossRefPubMed

26.

Andrew DJ, Lindsay CD (1998) Protection of human upper respiratory tract cell lines against sulfur mustard toxicity by glutathione esters. Hum Exp Toxicol 17:387–395CrossRefPubMed

27.

Gross CL, Giles KC, Smith WJ (1997) l-oxothiazolidine 4-carboxylate pretreatment of isolated human peripheral blood lymphocytes reduces sulfur mustard cytotoxicity. Cell Biol Toxicol 13:167–173CrossRefPubMed

28.

Elsayed NM, Omaye ST, Klain GJ, Inase JL, Dahlberg ET, Wheeler CR, Korte DW Jr (1989) Response of mouse brain to a single subcutaneous injection of the monofunctional sulfur mustard, butyl 2-chloroethyl sulfide (BCS). Toxicology 58:11–20CrossRefPubMed

29.

Ray R, Legere RH, Majerus BJ, Petrali JP (1995) Sulfur mustard-induced increase in intracellular free calcium level and arachidonic acid release from cell membrane. Toxicol Appl Pharmacol 131:44–52CrossRefPubMed

30.

Jörres RA, Holz O, Zachgo W, Timm P, Koschyk S, Müller B, Grimminger F, Seeger W, Kelly FJ, Dunster C, Frischer T, Lubec G, Waschewski M, Niendorf A, Magnussen H (2000) The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. Am J Respir Crit Care Med 161:1855–1861PubMed

31.

Bhisey RA, Bagwe AN, Mahimkar MB, Buch SC (1999) Biological monitoring of bidi industry workers occupationally exposed to tobacco. Toxicol Lett 108:259–265CrossRefPubMed

32.

Soltan-Sharifi MS, Mojtahedzadeh M, Najafi A, Reza Khajavi M, Reza Rouini M, Moradi M, Mohammadirad A, Abdollahi M (2007) Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms. Hum Exp Toxicol 26(9):697–703CrossRefPubMed

33.

Bunnell E, Pacht ER (1993) Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 148:1174–1178PubMed

34.

Roum JH, Buhl R, McElvaney NG, Borok Z, Crystal RG (1993) Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol 75:2419–2424PubMed

35.

Smith LJ, Houston M, Anderson J (1993) Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. Am Rev Respir Dis 147:1461–1464PubMed

36.

Kelly FJ, Mudway I, Blomberg A, Frew A, Sandström T (1999) Altered lung antioxidant status in patients with mild asthma. Lancet 354(9177):482–483CrossRefPubMed

37.

Morrison D, Rahman I, Lannan S, MacNee W (1999) Epithelial permeability, inflammation, and oxidant status in the air spaces of chronic smokers. Am J Respir Crit Care Med 159:473–479PubMed

38.

Duan X, Buckpitt AR, Pinkerton KE, Ji C, Plopper GG (1996) Ozone-induced alterations in glutathione in lung sub-compartments of rats and monkeys. Am J Respir Cell Mol Biol 14:70–75PubMed

39.

Comhair SA, Bhathena PR, Farver C, Thunnissen FB, Erzurum SC (2001) Extracellular glutathione peroxidase induction in asthmatic lungs: evidence for redox regulation of expression in human airway epithelial cells. FASEB J 15:70–78CrossRefPubMed

40.

Fidan F, Unlu M, Koken T, Tetik L, Akgun S, Demirel R, Serteser M (2005) Oxidant–antioxidant status and pulmonary function in welding workers. J Occup Health 47:286–292CrossRefPubMed

41.

Yaren H, Mollaoglu H, Kurt B, Korkmaz A, Oter S, Topal T, Karayilanoglu T (2007) Lung toxicity of nitrogen mustard may be mediated by nitric oxide and peroxynitrite in rats. Res Vet Sci 83:116–122CrossRefPubMed

42.

Ucar M, Korkmaz A, Reiter RJ, Yaren H, Oter S, Kurt B, Topal T (2007) Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol Lett 173:124–131CrossRefPubMed

43.

Oda Y, Kai H, Takahama K, Miyata T (1990) Changes in lipid peroxides content and antioxidant enzyme activities on airway surface in SO₂-induced bronchitic rats. Yakugaku Zasshi 110:612–616PubMed

44.

Chen H, Pellett LJ, Andersen HJ, Tappel AL (1993) Protection by vitamin E. Selenium, and b-carotene against oxidative damage in rat liver slices and homogenate. Free Radical Biol Med 14(5):473–482CrossRef

45.

Li GF, He YF, Huang MR, Guo JL, Wu QT, Chen SJ (2003) Determination of serum superoxide dismutase, glutathione peroxidase, total antioxidative capacity, malondialdehyde in patients with pneumonia. Di Yi Jun Yi Da Xue Xue Bao 23:961–962 in ChinesePubMed

46.

Husain K, Dube SN, Sugendran K, Singh R, Das Gupta S, Somani SM (1996) Effect of topically applied sulfur mustard on antioxidant enzymes in blood cells and body tissues of rats. J Appl Toxicol 16:245–248CrossRefPubMed

47.

Linden M, Rasmussen JB, Piitulainen E, Tunek A, Larson M, Tegner H, Venge P, Laitinen LA, Brattsand R (1993) Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis 148:1226–1232PubMed

48.

Rahman I, Swarska E, Henry M, Stolk J, Macnee W (2000) Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 55:189–193CrossRefPubMed

49.

Rahman I (2005) Regulation of glutathione in inflammation and chronic lung diseases. Mutat Res 579(1-2):58–80PubMed

Titel: Glutathione and Malondialdehyde Levels in Late Pulmonary Complications of Sulfur Mustard Intoxication
verfasst von: Majid Shohrati
Mostafa Ghanei
Navvab Shamspour
Fatemeh Babaei
Majid Norozi Abadi
Mahvash Jafari
Amini Harandi Ali
Publikationsdatum: 01.02.2010
Verlag: Springer-Verlag
Erschienen in: Lung / Ausgabe 1/2010
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-009-9178-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2010

Solitary Pulmonary Nodules Caused by Mycobacterium tuberculosis and Mycobacterium avium Complex

Serum Protein Profiling of Smear-Positive and Smear-Negative Pulmonary Tuberculosis Using SELDI-TOF Mass Spectrometry

Upper-Airway Cough Syndrome with Latent Eosinophilic Bronchitis

Erratum to: Glutathione and Malondialdehyde Levels in Late Pulmonary Complications of Sulfur Mustard Intoxication

Factors Associated with Mortality in Hospitalized Patients with Newly Diagnosed Tuberculosis

Dexamethasone and Cyclic AMP Regulate Sodium Phosphate Cotransporter (NaPi-IIb and Pit-1) mRNA and Phosphate Uptake in Rat Alveolar Type II Epithelial Cells